http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190007646-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3164a963ca21cec1151213cb1bb95e77 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-133 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-133 |
| filingDate | 2017-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdd1a152b7d8d2cd3934356aaa0171a7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6176de5eafb69d93374463c9db604df0 |
| publicationDate | 2019-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20190007646-A |
| titleOfInvention | Composition for suppression of cancer metastasis containing phytosphingosine |
| abstract | The present invention relates to a composition for inhibiting cancer metastasis comprising phytosphingosine, and more particularly, to a composition for inhibiting cancer metastasis by inhibiting epithelial mesenchymal transition and cancer stem cell growth at the same time. The composition according to the present invention contains phytosphingosine as an active ingredient and the phytosphingosine simultaneously inhibits epithelial mesenchymal transition and growth of cancer stem cells to effectively inhibit metastasis of cancer cells and thus exhibits the original therapeutic effect of cancer . |
| priorityDate | 2017-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 93.